NVIDIA Insider Plans $8M Stock Sale as Shares Trade Near Record Highs

Nvidia insider Form 144 filing reveals planned sale of 54,467 shares with an aggregate market value of $7,999,955.57 through broker Rockefeller Capital Management.

Rhea-AI Filing Summary

Nvidia insider Form 144 filing reveals planned sale of 54,467 shares with an aggregate market value of $7,999,955.57 through broker Rockefeller Capital Management. The securities were originally acquired as stock options on August 12, 2004.

Recent trading activity shows the Rosemary and A Brooke Seawell Rev Trust has conducted two previous sales in June 2025:

• June 20: 55,282 shares for $7,999,885.00
• June 23: 55,681 shares for $7,999,891.98

The proposed sale represents a minimal portion of Nvidia's 24.4 billion outstanding shares. The transaction is scheduled for execution on the Nasdaq around June 24, 2025. This Form 144 filing, required for proposed sales by affiliates, confirms the seller has no knowledge of undisclosed material adverse information about Nvidia's operations.

Positive

• None.

Negative

• Insider sale of 54,467 shares worth approximately $8 million by trust associated with company insider
• Pattern of significant insider selling with three separate transactions totaling over $24 million in the past 3 months from the same trust

FAQ

How many NVDA shares are being sold according to the June 2025 Form 144 filing?

According to the Form 144 filing, 54,467 shares of NVDA common stock are proposed to be sold through Rockefeller Capital Management, with an aggregate market value of $7,999,955.57.

When did the NVDA insider originally acquire these shares being sold?

The shares were originally acquired on August 12, 2004 through stock options from NVDA, with the initial payment made on February 12, 2004 via cash/check.

What recent NVDA stock sales were disclosed by the same seller in the past 3 months?

The seller (Rosemary and A Brooke Seawell Rev Trust) made two recent sales: 55,282 shares on June 20, 2025 for $7,999,885.00, and 55,681 shares on June 23, 2025 for $7,999,891.98.

What is the total market value of NVDA shares proposed for sale in this Form 144?

The total aggregate market value of the NVDA shares proposed for sale is $7,999,955.57, representing 54,467 shares to be sold on the Nasdaq exchange.

When is the approximate date of sale for the NVDA shares in this Form 144?

The approximate date of sale for the NVDA shares is listed as June 24, 2025, to be executed on the Nasdaq exchange.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/24/2025 - 01:19 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001197652
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NVIDIA CORP
SEC File Number	000-23985
Address of Issuer	2788 SAN TOMAS EXPRESSWAY SANTA CLARA CALIFORNIA 95051
Phone	408-486-2000
Name of Person for Whose Account the Securities are To Be Sold	SEAWELL A BROOKE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Rockefeller Capital Management Two Embarcadero Center Suite 232 San Francisco CA 94111	54467	7999955.57	24400000000	06/24/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/12/2004	Stock Options	NVDA			54467	02/12/2004	cash/check

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Rosemary and A Brooke Seawell Rev Trust 2788 San Tomas Expressway Santa Clara CA 95051	NVIDIA	06/20/2025	55282	7999885.00
Rosemary and A Brooke Seawell Rev Trust 2788 San Tomas Expressway, Santa Clara CA 95051	NVIDIA	06/23/2025	55681	7999891.98

144: Remarks and Signature

Remarks	Shares sold from the following Trust account: ROSEMARY AND A. BROOKE SEAWELL REV TR
Date of Notice	06/24/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/19/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Carmen Zamores as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for SEAWELL A BROOKE
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)